| Views | |
|---|---|
| Therapies with CCL25 require controlled release via microparticles to avoid strong inflammatory reactions | 112 |
| November 2024 | December 2024 | January 2025 | February 2025 | March 2025 | April 2025 | May 2025 | |
|---|---|---|---|---|---|---|---|
| Therapies with CCL25 require controlled release via microparticles to avoid strong inflammatory reactions | 4 | 3 | 6 | 0 | 8 | 11 | 2 |
| Views | |
|---|---|
| 2021_Spinnen_etal.pdf | 51 |
